NCT01329185View on ClinicalTrials.gov

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
EBV ViremiaCMV Viremia
Interventions
DRUG

Valganciclovir

Valganciclovir 450mg twice a day for 14 days prior to transplant date

DRUG

Placebo

1 capsule twice a day for 14 days prior to transplant date

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT01329185 - Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients | Biotech Hunter | Biotech Hunter